Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections.
作者信息
Abu-Raddad Laith J, Chemaitelly Hiam, Bertollini Roberto
机构信息
Weill Cornell Medicine-Qatar, Doha, Qatar
Ministry of Public Health, Doha, Qatar.
出版信息
N Engl J Med. 2021 Dec 23;385(26):2487-2489. doi: 10.1056/NEJMc2108120. Epub 2021 Nov 24.
Abstract
摘要
相似文献
1
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections.与初次感染相比，SARS-CoV-2再次感染的严重程度。
N Engl J Med. 2021 Dec 23;385(26):2487-2489. doi: 10.1056/NEJMc2108120. Epub 2021 Nov 24.
2
Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.卡塔尔初级保健机构就诊患者中新冠病毒核酸检测复阳率。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.10.029. Epub 2020 Nov 2.
3
SARS-CoV-2 re-infection: a case report from Qatar.严重急性呼吸综合征冠状病毒2型再次感染：卡塔尔的一例病例报告。
J Infect. 2021 Mar;82(3):414-451. doi: 10.1016/j.jinf.2020.10.019. Epub 2020 Oct 25.
4
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.SARS-CoV-2 再感染可疑病例的发生率和严重程度在一组 PCR 阳性 COVID-19 患者中的研究。
Clin Microbiol Infect. 2021 Dec;27(12):1860.e7-1860.e10. doi: 10.1016/j.cmi.2021.07.030. Epub 2021 Aug 19.
5
COVID-19 reinfections.COVID-19 再感染。
Epidemiol Mikrobiol Imunol. 2021 Spring;70(1):62-67.
6
COVID-19 re-infection.新冠病毒再次感染
Eur J Clin Invest. 2021 May;51(5):e13537. doi: 10.1111/eci.13537. Epub 2021 Mar 17.
7
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.在高强度再暴露环境下评估严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）再感染的风险。
Clin Infect Dis. 2021 Oct 5;73(7):e1830-e1840. doi: 10.1093/cid/ciaa1846.
8
Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk.有症状的 SARS-CoV-2 再感染：医护人员和免疫抑制个体为高危人群。
BMC Infect Dis. 2021 Sep 6;21(1):923. doi: 10.1186/s12879-021-06643-1.
9
[Covid-19 reinfections: what is the clinical relevance?].[新型冠状病毒肺炎再感染：临床意义是什么？]
Ned Tijdschr Geneeskd. 2020 Dec 3;164:D5640.
10
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.2020 年 5 月至 7 月期间可能发生严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）再感染患者的临床和实验室发现。
Clin Infect Dis. 2021 Dec 16;73(12):2217-2225. doi: 10.1093/cid/ciab148.
引用本文的文献
1
Epidemiological patterns of SARS-CoV-2 reinfections in Espírito Santo, Brazil: A population-based analysis using integrated surveillance and vaccination data.巴西圣埃斯皮里图州新冠病毒再次感染的流行病学模式：一项基于人群的分析，使用综合监测和疫苗接种数据
PLoS One. 2025 Sep 10;20(9):e0331771. doi: 10.1371/journal.pone.0331771. eCollection 2025.
2
Clinical and immunological insights into SARS-CoV-2 reinfection: a propensity score-matched cohort study.对严重急性呼吸综合征冠状病毒2型再次感染的临床和免疫学见解：一项倾向评分匹配队列研究。
BMC Infect Dis. 2025 Aug 1;25(1):970. doi: 10.1186/s12879-025-11398-0.
3
Sustained natural immunity following SARS-CoV-2 infection against severe COVID-19 outcomes and symptomatic reinfection: analyses of national data for Brazil and Scotland.SARS-CoV-2感染后针对严重COVID-19结局和有症状再感染的持续自然免疫：巴西和苏格兰的国家数据分析
BMJ Open. 2025 Jul 16;15(7):e104057. doi: 10.1136/bmjopen-2025-104057.
4
Immune histories and natural infection protection during the omicron era.奥密克戎时代的免疫史与自然感染防护
Commun Med (Lond). 2025 Jul 1;5(1):262. doi: 10.1038/s43856-025-00974-9.
5
Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar.评估新冠病毒疫苗有效性研究中的健康接种者效应：卡塔尔的一项全国队列研究。
Elife. 2025 Jun 9;14:e103690. doi: 10.7554/eLife.103690.
6
Studying Disease Reinfection Rates, Vaccine Efficacy, and the Timing of Vaccine Rollout in the Context of Infectious Diseases: A COVID-19 Case Study.在传染病背景下研究疾病再感染率、疫苗效力及疫苗推广时机：以新冠疫情为例
Int J Environ Res Public Health. 2025 May 3;22(5):731. doi: 10.3390/ijerph22050731.
7
Coronavirus Disease 2019 Symptoms by Immunity Status and Predominant-Variant Period Among US Blood Donors.美国献血者中2019冠状病毒病症状与免疫状态及主要变异株流行时期的关系
Open Forum Infect Dis. 2025 Mar 26;12(5):ofaf185. doi: 10.1093/ofid/ofaf185. eCollection 2025 May.
8
1, 2, and 3+ SARS-CoV-2 infections: associations of prior infections with protection and severity.1、2和3次及以上严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染：既往感染与保护作用及严重程度的关联
medRxiv. 2025 Apr 8:2025.04.07.25324191. doi: 10.1101/2025.04.07.25324191.
9
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar.评估医院入院数据作为新冠病毒疾病严重程度的指标：卡塔尔的一项全国性评估。
Open Forum Infect Dis. 2025 Feb 17;12(3):ofaf098. doi: 10.1093/ofid/ofaf098. eCollection 2025 Mar.
10
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar.新冠疫情期间COVID-19严重程度和死亡率的转折点：卡塔尔的一项全国队列研究
BMJ Public Health. 2023 Oct 29;1(1):e000479. doi: 10.1136/bmjph-2023-000479. eCollection 2023 Nov.
Zotero 插件